Search for Clinical Trial Results

Sponsored By

Merkel Cell Carcinoma - 3 Studies Found

Status Study
RECRUITING Study Name: Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
Condition: Merkel Cell Carcinoma
Date: 2024-09-16
Interventions: Pembrolizumab 400mg IV
RECRUITING Study Name: Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma
Condition: Merkel Cell Carcinoma
Date: 2024-09-16
Interventions: 400mg IV
RECRUITING Study Name: Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
Condition: Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
Date: 2024-09-16
Interventions: Undergo tumor biopsy